Cases Age/sex Monoclonal protein Duration (years) Therapy
Korting et al 5 37/F IgG κ 2 Improvement after myeloma therapy
Doyle et al 6 58/F 62/F NA 4 40 NA
Ohta et al 7 64/M IgG κ 11 Improvement after myeloma therapy
Hodak et al 8 74/F IgG κ 4 Improved after 1.5 years of melphalan
Rimon et al 9 62/F IgG λ 22 NA
Salisbury et al10 76/F IgA κ 0.1 Improvement after 9 months of cyclophosphamide and prednisolone
Nakanishi et al 11 50/M IgG κ 3 NA
Schmidt et al 12 46/M IgG λ 22 NA
Pujol et al 13 74/M IgA κ 15 Improvement after myeloma therapy
Valente et al 14 56/F IgA κ 6 Improvement after melphalan and prednisolone
Bachleitner-Hoffman et al 15 73/F IgG 24 Improvement after vincristine, melphalan, cyclophosphamide and prednisolone
Colovic et al 16 55/F IgG λ 20 Improvement after 6 cycles of endoxan, thalidomide and dexamethasone
Smeeta Gajendra etal 2 24/M IgA κ 8 Improvement after 9 months of thalidomide and dexamethasone